Active
TERM 1
January 24, 2025 · 478 days ago
🏥 Healthcare
On January 24, 2025, President Trump signed Executive Order 14182 directing federal agencies to enforce the Hyde Amendment, which prohibits federal funds from being used to pay for abortion services except in cases of rape, incest, or danger to the mother's life. The order requires agencies to withhold federal funding from any organization that provides, refers for, or covers abortion services. The confirmed direct impact includes potential loss of federal funding for Planned Parenthood and other healthcare providers that offer abortion services alongside other medical care.
Active
TERM 2
January 23 2025 · 479 days ago
🏥 Healthcare
The Trump administration reversed its policy allowing federal funds for purchasing and distributing fentanyl detection strips used to test street drugs for contaminants. The Substance Abuse and Mental Health Services Administration issued guidance ending the practice as part of the administration's opposition to harm reduction initiatives. This change eliminates access to potentially life-saving drug testing resources for vulnerable populations.
Active
TERM 2
January 23 2025 · 479 days ago
🏥 Healthcare
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana to a less-dangerous drug category under federal law. The change impacts federal regulation of marijuana in dozens of states that permit medical use, though it does not fully legalize marijuana federally. This significantly alters how the drug is regulated and enforced at the federal level.
Active
TERM 2
January 21 2025 · 481 days ago
🏥 Healthcare
The FDA appointed Katherine Szarama as acting director of the Center for Biologics Evaluation and Research, replacing Vinay Prasad. This unit regulates vaccines and biological products for human use. The leadership change may impact vaccine approval processes and biological product oversight.
Active
TERM 1
January 20, 2025 · 482 days ago
🏥 Healthcare
On January 20, 2025, President Trump signed Executive Order 14155 directing the withdrawal of the United States from the World Health Organization. The order initiates the process to cease U.S. participation in the WHO and discontinue financial contributions to the organization. The direct impact includes halting U.S. funding to WHO programs and ending American involvement in WHO decision-making and global health coordination mechanisms.
Active
TERM 2
January 18 2025 · 484 days ago
🏥 Healthcare
President Trump signed an executive order directing the FDA to accelerate review of psychedelic drugs including ibogaine for medical treatment. The order aims to speed access to psychedelic-based therapies, particularly for treating post-traumatic stress disorder in military veterans. The reform could expand availability of these treatments to Americans seeking alternative mental health interventions.
Active
TERM 2
January 18 2025 · 484 days ago
🏥 Healthcare
President Trump signed an executive order to accelerate research on psychedelic drugs for treating mental health disorders. The order aims to expedite clinical trials and regulatory pathways for these substances. This could expand treatment options for Americans suffering from depression, PTSD, and other mental health conditions.
Active
TERM 1
August 6, 2020 · 2,110 days ago
🏥 Healthcare
Executive Order 13944 was signed on August 6, 2020, directing federal agencies to prioritize domestic production of essential medicines, medical countermeasures, and critical inputs needed for public health emergencies. The order established requirements for federal procurement preferences and directed the Department of Health and Human Services and Department of Defense to assess supply chain vulnerabilities and develop strategies to increase domestic manufacturing capacity. Confirmed effects included increased federal contracting focus on domestic suppliers and initiation of supply chain assessments, though full implementation of domestic production expansion occurred over subsequent months.
Active
TERM 1
April 20, 2020 · 2,218 days ago
🏥 Healthcare
On April 20, 2020, President Trump signed a memorandum directing continued federal funding and support for governors' deployment of National Guard units to respond to COVID-19 and support economic recovery efforts. The memorandum authorized the Department of Defense to provide financial assistance, equipment, and logistical support for state-activated National Guard personnel engaged in pandemic response activities. This action enabled states to utilize National Guard resources for tasks including testing, contact tracing, distribution of medical supplies, and support to healthcare facilities without states bearing the full operational costs.
Active
TERM 1
March 23, 2020 · 2,246 days ago
🏥 Healthcare
On March 23, 2020, President Trump signed Executive Order 13910, authorizing the Department of Health and Human Services to use the Defense Production Act to prevent hoarding and price gouging of health and medical resources needed for COVID-19 response. The order directed federal agencies to take action against the accumulation and retention of scarce health and medical resources, and established enforcement mechanisms for violations. The confirmed effect was to give federal authorities legal tools to address supply chain disruptions and ensure allocation of ventilators, personal protective equipment, and other critical medical supplies during the pandemic.